R

Roivant Sciences

Biopharmaceutical company developing RNA therapeutics

Accounting Operations Associate

Financial AccountingUpdated on Nov 14
Full-timeNew York, NY, USA$75k - $105k /yr

About the Job

Requirements

  • 2–5 years of relevant experience.
  • A bachelor's degree is required, preferably in Accounting, Business, Finance, or a related field.
  • Strong enterprise resource planning (ERP) experience and experience with related financial systems.
  • Self-direction and proactive problem-solving ability.
  • A process-oriented approach and interest in continuous improvement.
  • Organization and attention to detail.

Responsibilities

  • Support and continuously improve accounting workflows, standard operating procedures, and related documentation.
  • Contribute to process optimization and system enhancement initiatives across the accounting function.
  • Partner with cross-functional stakeholders to simplify, automate, or eliminate manual steps.
  • Monitor process performance and drive ongoing improvements to accuracy and efficiency.
  • Support internal controls and respond to audit requests, including process mapping and flowcharting to document and strengthen compliance across accounting workflows.
  • Provide operational support across Accounting Operations functions as capacity allows.
  • Assist with reporting needs and ad hoc analysis to support broader Accounting and Finance initiatives.

Desired Qualifications

  • Experience supporting month-end close and/or working in SOX-controlled environments.
  • Experience with NetSuite is preferred; experience with Coupa and Concur is a plus.
  • Pharmaceutical experience with clinical trials.

About the Company

Roivant Sciences

Biopharmaceutical company developing RNA therapeutics

Roivant Sciences develops and commercializes medicines through in-house programs and strategic partnerships, with a focus on genetic disorders and RNA therapeutics. Its Genevant subsidiary uses proprietary delivery platforms to create RNA-based treatments, including mRNA, RNA interference, and gene editing. Revenue comes from developing drug candidates, licensing and collaborations, and selling approved drugs. The goal is to bring effective therapies to patients more quickly by combining technology platforms with partner networks.

Company size
201-500
Company stage
IPO
Headquarters
New York City, New York
Founded
2014

Recently Posted Jobs

Explore more opportunities at Roivant Sciences

See more jobs